South-Eastern Asia: Antisera Market 2024

Antisera Market Size in South-Eastern Asia

In 2022, the Southeast Asian antisera market decreased by X% to $X for the first time since 2016, thus ending a five-year rising trend. In general, consumption, however, enjoyed a resilient increase. The level of consumption peaked at $X in 2021, and then shrank dramatically in the following year.

Antisera Production in South-Eastern Asia

In value terms, antisera production reduced slightly to $X in 2022 estimated in export price. Overall, production, however, saw a strong expansion. The growth pace was the most rapid in 2018 with an increase of X%. The level of production peaked at $X in 2019; however, from 2020 to 2022, production failed to regain momentum.

Antisera Exports

Exports in South-Eastern Asia

For the fourth consecutive year, South-Eastern Asia recorded growth in overseas shipments of antisera and other blood fractions, which increased by X% to X tons in 2022. Overall, exports saw a significant expansion. The growth pace was the most rapid in 2017 when exports increased by X%. As a result, the exports reached the peak of X tons. From 2018 to 2022, the growth of the exports remained at a somewhat lower figure.

In value terms, antisera exports reached $X in 2022. Over the period under review, exports showed a significant expansion. The most prominent rate of growth was recorded in 2018 when exports increased by X% against the previous year. The level of export peaked in 2022 and is likely to continue growth in the near future.

Exports by Country

The shipments of the one major exporters of antisera and other blood fractions, namely Singapore, represented more than two-thirds of total export.

Singapore was also the fastest-growing in terms of the antisera and other blood fractions exports, with a CAGR of X% from 2012 to 2022. While the share of Singapore (X p.p.) increased significantly, the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Singapore ($X) also remains the largest antisera supplier in South-Eastern Asia.

In Singapore, antisera exports expanded at an average annual rate of X% over the period from 2012-2022.

Export Prices by Country

The export price in South-Eastern Asia stood at $X per ton in 2022, shrinking by X% against the previous year. Over the period under review, the export price saw a relatively flat trend pattern. The growth pace was the most rapid in 2018 when the export price increased by X% against the previous year. The level of export peaked at $X per ton in 2014; however, from 2015 to 2022, the export prices remained at a lower figure.

As there is only one major export destination, the average price level is determined by prices for Singapore.

From 2012 to 2022, the rate of growth in terms of prices for Singapore amounted to X% per year.

Antisera Imports

Imports in South-Eastern Asia

After five years of growth, purchases abroad of antisera and other blood fractions decreased by X% to X tons in 2022. Overall, imports, however, posted a significant increase. The growth pace was the most rapid in 2013 with an increase of X%. Over the period under review, imports attained the peak figure at X tons in 2021, and then reduced in the following year.

In value terms, antisera imports reduced to $X in 2022. Over the period under review, imports, however, showed prominent growth. The growth pace was the most rapid in 2020 with an increase of X%. Over the period under review, imports hit record highs at $X in 2021, and then declined in the following year.

Imports by Country

In 2022, Singapore (X tons) was the largest importer of antisera and other blood fractions, generating X% of total imports. It was distantly followed by the Philippines (X tons), Malaysia (X tons), Thailand (X tons) and Vietnam (X tons), together achieving a X% share of total imports. Myanmar (X tons) and Indonesia (X tons) held a minor share of total imports.

From 2012 to 2022, average annual rates of growth with regard to antisera imports into Singapore stood at X%. At the same time, Vietnam (X%), Myanmar (X%), the Philippines (X%), Malaysia (X%), Thailand (X%) and Indonesia (X%) displayed positive paces of growth. Moreover, Vietnam emerged as the fastest-growing importer imported in South-Eastern Asia, with a CAGR of X% from 2012-2022. While the share of the Philippines (X p.p.), Vietnam (X p.p.), Myanmar (X p.p.) and Singapore (X p.p.) increased significantly in terms of the total imports from 2012-2022, the share of Malaysia (X p.p.), Indonesia (X p.p.) and Thailand (X p.p.) displayed negative dynamics.

In value terms, Singapore ($X) constitutes the largest market for imported antisera and other blood fractions in South-Eastern Asia, comprising X% of total imports. The second position in the ranking was taken by Thailand ($X), with a X% share of total imports. It was followed by the Philippines, with a X% share.

In Singapore, antisera imports expanded at an average annual rate of X% over the period from 2012-2022. In the other countries, the average annual rates were as follows: Thailand (X% per year) and the Philippines (X% per year).

Import Prices by Country

In 2022, the import price in South-Eastern Asia amounted to $X per ton, which is down by X% against the previous year. Over the period under review, the import price recorded a abrupt setback. The pace of growth was the most pronounced in 2018 an increase of X% against the previous year. The level of import peaked at $X per ton in 2012; however, from 2013 to 2022, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Indonesia ($X per ton), while Myanmar ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Indonesia (X%), while the other leaders experienced a decline in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :